Neurotech extends licence to include all neurological disorders by Martin Lane March 3, 2021April 26, 2024 ASX-listed Neurotech International has announced the expansion of its exclusive licence with Dolce Cann Global to […]
Neurotech International completes in-vitro studies of its proprietary cannabis leads, clinical trials to follow by Martin Lane December 22, 2020April 26, 2024
Neurotech International’s new chairman to focus on cannabis treatments for cognitive disorders by Emma Castle November 2, 2020April 26, 2024
Unique strains of cannabis may hold key to autism treatment by Emma Castle September 22, 2020April 26, 2024
